These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22380522)

  • 1. Comparison of a rational vs. high throughput approach for rapid salt screening and selection.
    Collman BM; Miller JM; Seadeek C; Stambek JA; Blackburn AC
    Drug Dev Ind Pharm; 2013 Jan; 39(1):29-38. PubMed ID: 22380522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of salt screening methodologies.
    Fernández Casares A; Nap WM; Ten Figás G; Huizenga P; Groot R; Hoffmann M
    J Pharm Pharmacol; 2015 Jun; 67(6):812-22. PubMed ID: 25683791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of aqueous content in small scale salt screening--improving hit rate for weakly basic, low solubility drugs.
    Tarsa PB; Towler CS; Woollam G; Berghausen J
    Eur J Pharm Sci; 2010 Sep; 41(1):23-30. PubMed ID: 20553863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of solid state properties on developability assessment of drug candidates.
    Huang LF; Tong WQ
    Adv Drug Deliv Rev; 2004 Feb; 56(3):321-34. PubMed ID: 14962584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound selection for development - is salt formation the ultimate answer? Experiences with an extended concept of the "100mg approach".
    Korn C; Balbach S
    Eur J Pharm Sci; 2014 Jun; 57():257-63. PubMed ID: 24036162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug salt formation via mechanochemistry: the case study of vincamine.
    Hasa D; Perissutti B; Cepek C; Bhardwaj S; Carlino E; Grassi M; Invernizzi S; Voinovich D
    Mol Pharm; 2013 Jan; 10(1):211-24. PubMed ID: 23186380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP; Holm R; Diego HL
    Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.
    David SE; Timmins P; Conway BR
    Drug Dev Ind Pharm; 2012 Jan; 38(1):93-103. PubMed ID: 22118222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput 96-well solvent mediated sonic blending synthesis and on-plate solid/solution stability characterization of pharmaceutical cocrystals.
    Luu V; Jona J; Stanton MK; Peterson ML; Morrison HG; Nagapudi K; Tan H
    Int J Pharm; 2013 Jan; 441(1-2):356-64. PubMed ID: 23178596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the influence of counterion on the properties of some amorphous organic salts.
    Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
    Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Selection of a Pharmaceutical Salt-The Effect of the Acidity of the Counterion on Its Solubility and Potential Biopharmaceutical Performance.
    He Y; Orton E; Yang D
    J Pharm Sci; 2018 Jan; 107(1):419-425. PubMed ID: 29107790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salt formation to improve drug solubility.
    Serajuddin AT
    Adv Drug Deliv Rev; 2007 Jul; 59(7):603-16. PubMed ID: 17619064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Preparation of 1:1 Haloperidol-Maleic Acid Salt by a Novel Solvent-Free Method Using a Twin Screw Melt Extruder.
    Lee HL; Vasoya JM; Cirqueira ML; Yeh KL; Lee T; Serajuddin AT
    Mol Pharm; 2017 Apr; 14(4):1278-1291. PubMed ID: 28245127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaction crystallization of pharmaceutical molecular complexes.
    Rodríguez-Hornedo N; Nehm SJ; Seefeldt KF; Pagan-Torres Y; Falkiewicz CJ
    Mol Pharm; 2006; 3(3):362-7. PubMed ID: 16749868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility prediction, solvate and cocrystal screening as tools for rational crystal engineering.
    Loschen C; Klamt A
    J Pharm Pharmacol; 2015 Jun; 67(6):803-11. PubMed ID: 25851032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spherical crystallization of drugs.
    Kovačič B; Vrečer F; Planinšek O
    Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystalline form information from multiwell plate salt screening by use of Raman microscopy.
    Kojima T; Onoue S; Murase N; Katoh F; Mano T; Matsuda Y
    Pharm Res; 2006 Apr; 23(4):806-12. PubMed ID: 16575500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ salt screening--a useful technique for discovery support and preformulation studies.
    Tong WQ; Whitesell G
    Pharm Dev Technol; 1998 May; 3(2):215-23. PubMed ID: 9653759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals.
    Yamamoto K; Tsutsumi S; Ikeda Y
    Int J Pharm; 2012 Nov; 437(1-2):162-71. PubMed ID: 22871562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.